Xiaowan Chen
Papers
1
Total Citations
1
H-Index
1
About
Xiaowan Chen is a leading urologic oncologist whose research focuses on advancing surgical precision and functional preservation in prostate cancer treatment. Chen’s most impactful work centers on the neurovascular structure-adjacent frozen-section examination (NeuroSAFE) technique, a novel approach to robot-assisted radical prostatectomy that aims to maximize oncological control while minimizing damage to critical nerves and blood vessels. Their landmark systematic review and meta-analysis, published in 2025, synthesizes data from two-arm comparative studies to evaluate functional and oncological outcomes of NeuroSAFE versus standard procedures. This work, already garnering citations, demonstrates Chen’s commitment to evidence-based surgical innovation, offering patients improved potency and continence without compromising cancer clearance. By systematically analyzing real-world outcomes, Chen provides surgeons with actionable insights to refine intraoperative decision-making. Their contributions bridge the gap between cutting-edge pathology and clinical practice, positioning Chen as a key figure in the evolution of nerve-sparing techniques. With a growing citation impact, Chen’s research continues to shape the future of minimally invasive urologic surgery, making them a vital resource for trainees and practitioners seeking to optimize patient quality of life after prostatectomy.
Research Focus
Key Achievements
Top Papers
- 1